Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX.
NCT00141128
Last updated date
ABOUT THIS STUDY
SS-RBX will be used to evaluate pharmacodynamic changes in urethral function using a novel
methodology
FOR MORE INFORMATION
Contact a representative by phone, email, or visiting the study website. Please see the references below:
By phone
Pfizer Clinical Trials Contact Center
1-800-718-1021
Eligibility Criteria
condition
Stress Urinary Incontinence
Sex
Female
Age
18-65 years
Inclusion Criteria
Show details
- Female
- Stress urinary incontinence
Exclusion Criteria
Show details
- Bladder outflow obstruction
- Neurological disease
NEED INFO?
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
Stress Urinary IncontinenceCanadian Experience With Contiform Intravaginal Device For The Treatment Of Stress Incontinence
NCT03614611
- Quebec,
Female
18 Years+
years
MULTIPLE SITES
Stress Urinary IncontinenceEvaluation Of The Ability Of Fesoterodine To Increase Urethral Pressure In Stress Urinary Incontinence Patients
NCT01042236
- Glostrup,
Female
18 Years+
years
MULTIPLE SITES
Stress Urinary IncontinenceEvaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX.
NCT00141128
- Glostrup,
Female
18 Years+
years
MULTIPLE SITES
Stress Urinary IncontinenceAn 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.
NCT00138749
- Anchorage, Alaska
- Sun City, Arizona
- Tucson, Arizona
- Tucson, Arizona
- Little Rock, Arkansas
- Atherton, California
- Carmichael, California
- Laguna Woods, California
- Murrieta, California
- Newport Beach, California
- Sacramento, California
- San Diego, California
- Tarzana, California
- Temecula, California
- Torrance, California
- Vista, California
- Aurora, Colorado
- Denver, Colorado
- Denver, Colorado
- Wheat Ridge, Colorado
- New London, Connecticut
- Waterbury, Connecticut
- Aventura, Florida
- New Port Richey, Florida
- Panama City, Florida
- Panama City, Florida
- Pembroke Pines, Florida
- Port Richey, Florida
- West Palm Beach, Florida
- Alpharetta, Georgia
- Coeur D Alene, Idaho
- Arlington Heights, Illinois
- Chicago, Illinois
- Melrose Park, Illinois
- Greenwood, Indiana
- Indianapolis, Indiana
- Des Moines, Iowa
- Louisville, Kentucky
- Shreveport, Louisiana
- Greenbelt, Maryland
- Watertown, Massachusetts
- Jackson, Mississippi
- Jackson, Mississippi
- Liberty, Missouri
- North Kansas City, Missouri
- Omaha, Nebraska
- Henderson, Nevada
- Edison, New Jersey
- West Orange, New Jersey
- Albuquerque, New Mexico
- Albany, New York
- Garden City, New York
- Garden City, New York
- Mineola, New York
- Poughkeepsie, New York
- Burlington, North Carolina
- Charlotte, North Carolina
- Concord, North Carolina
- Fayetteville, North Carolina
- Winston-salem, North Carolina
- Cincinnati, Ohio
- Bethany, Oklahoma
- Eugene, Oregon
- Eugene, Oregon
- Medford, Oregon
- Portland, Oregon
- Colmar, Pennsylvania
- Lancaster, Pennsylvania
- Philadelphia, Pennsylvania
- Pittsburgh, Pennsylvania
- Sellersville, Pennsylvania
- Sewickley, Pennsylvania
- Providence, Rhode Island
- Charleston, South Carolina
- Columbia, South Carolina
- Greer, South Carolina
- Myrtle Beach, South Carolina
- Knoxville, Tennessee
- Knoxville, Tennessee
- Corpus Christi, Texas
- Corsicana, Texas
- Houston, Texas
- San Antonio, Texas
- Salt Lake City, Utah
- Sandy, Utah
- Sandy, Utah
- West Jordan, Utah
- Virginia Beach, Virginia
- Seattle, Washington
- Surrey, British Columbia
- Victoria, British Columbia
- Kitchener, Ontario
- Oakville, Ontario
- Montreal, Quebec
- Pointe-Claire, Quebec
Female
18 Years+
years
MULTIPLE SITES
Advanced Information
Descriptive Information | ||||
---|---|---|---|---|
Brief Title ICMJE | Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX. | |||
Official Title ICMJE | Measurement Of Urethral Function In Women With Stress Urinary Incontinence - Evaluation Of The Sensitivity Of Urethral Reflectometry Compared To Urethral Pressure Profilometry, Using [S,S]-Reboxetine To Detect Pharmacological Augmentation Of Urethral Pressure. | |||
Brief Summary | SS-RBX will be used to evaluate pharmacodynamic changes in urethral function using a novel methodology | |||
Detailed Description | Not Provided | |||
Study Type ICMJE | Interventional | |||
Study Phase ICMJE | Phase 2 | |||
Study Design ICMJE | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Double Primary Purpose: Treatment | |||
Condition ICMJE | Urinary Incontinence, Stress | |||
Intervention ICMJE | Drug: SS-RBX | |||
Study Arms ICMJE | Not Provided | |||
Publications * | Klarskov N, Scholfield D, Soma K, Darekar A, Mills I, Lose G. Measurement of urethral closure function in women with stress urinary incontinence. J Urol. 2009 Jun;181(6):2628-33; discussion 2633. doi: 10.1016/j.juro.2009.01.114. Epub 2009 Apr 16. | |||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. | ||||
Recruitment Information | ||||
Recruitment Status ICMJE | Completed | |||
Actual Enrollment ICMJE | 18 | |||
Original Enrollment ICMJE | 40 | |||
Actual Study Completion Date ICMJE | June 2006 | |||
Primary Completion Date | Not Provided | |||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
| |||
Sex/Gender ICMJE |
| |||
Ages ICMJE | 18 Years to 65 Years (Adult, Older Adult) | |||
Accepts Healthy Volunteers ICMJE | No | |||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | |||
Listed Location Countries ICMJE | Denmark | |||
Removed Location Countries | ||||
Administrative Information | ||||
NCT Number ICMJE | NCT00141128 | |||
Other Study ID Numbers ICMJE | A6061024 | |||
Has Data Monitoring Committee | Not Provided | |||
U.S. FDA-regulated Product | Not Provided | |||
IPD Sharing Statement ICMJE | Not Provided | |||
Responsible Party | Not Provided | |||
Study Sponsor ICMJE | Pfizer | |||
Collaborators ICMJE | Not Provided | |||
Investigators ICMJE |
| |||
PRS Account | Pfizer | |||
Verification Date | May 2011 | |||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |